Proadrenomedullin: An effective prognostic biomarker in septic patients
Autoria(s):
Cortés, M.; Mayor, M.; García-Torre, A.; Castro-Vega, I.; Enguix-Armada, A.
Data(s)
21/10/2015
21/10/2015
01/07/2014
Resumo
Background: Measurement of biomarkers is a potential approach to early prediction of mortality in septic patients. The purpose of this study was to asses the prognostic value of proadrenomedullin (pADM) in adult patients with sepsis with a single measurement in the first 24 hours after the onset of severe sepsis or septic shock.
Conclusions: The protein pADM is an important prognostic biomarker of survival when measured on admission of septic patients to the ICU.
Meeting abstract
Identificador
Cortés M., Mayor M., García-Torre Á., Castro-Vega I., Enguix-Armada A. Proadrenomedullin: An effective prognostic biomarker in septic patients. 2014;52(Suppl. 1):S944